171 related articles for article (PubMed ID: 9753710)
1. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation.
Ristow M; Müller-Wieland D; Pfeiffer A; Krone W; Kahn CR
N Engl J Med; 1998 Oct; 339(14):953-9. PubMed ID: 9753710
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2).
Duque G; Macoritto M; Kremer R
Exp Gerontol; 2004 Mar; 39(3):333-8. PubMed ID: 15036392
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis.
Saladin R; Fajas L; Dana S; Halvorsen YD; Auwerx J; Briggs M
Cell Growth Differ; 1999 Jan; 10(1):43-8. PubMed ID: 9950217
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.
Lei HH; Chen MH; Yang WS; Chiu MC; Chen MC; Tai TY; Chuang LM
Metabolism; 2000 Oct; 49(10):1267-70. PubMed ID: 11079814
[TBL] [Abstract][Full Text] [Related]
6. Regulation of activating transcription factor-2 in early stage of the adipocyte differentiation program.
Lee MY; Kong HJ; Cheong J
Biochem Biophys Res Commun; 2001 Mar; 281(5):1241-7. PubMed ID: 11243868
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation.
Oishi Y; Manabe I; Tobe K; Tsushima K; Shindo T; Fujiu K; Nishimura G; Maemura K; Yamauchi T; Kubota N; Suzuki R; Kitamura T; Akira S; Kadowaki T; Nagai R
Cell Metab; 2005 Jan; 1(1):27-39. PubMed ID: 16054042
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity.
Permana PA; Nair S; Lee YH; Luczy-Bachman G; Vozarova De Courten B; Tataranni PA
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E958-62. PubMed ID: 14970008
[TBL] [Abstract][Full Text] [Related]
9. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations.
Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF
N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666
[TBL] [Abstract][Full Text] [Related]
10. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
Ringel J; Engeli S; Distler A; Sharma AM
Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
[TBL] [Abstract][Full Text] [Related]
11. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.
Clément K; Vaisse C; Manning BS; Basdevant A; Guy-Grand B; Ruiz J; Silver KD; Shuldiner AR; Froguel P; Strosberg AD
N Engl J Med; 1995 Aug; 333(6):352-4. PubMed ID: 7609752
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes.
Sewter C; Blows F; Considine R; Vidal-Puig A; O'Rahilly S
J Clin Endocrinol Metab; 2002 Sep; 87(9):4203-7. PubMed ID: 12213872
[TBL] [Abstract][Full Text] [Related]
15. Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects.
Hamann A; Münzberg H; Buttron P; Büsing B; Hinney A; Mayer H; Siegfried W; Hebebrand J; Greten H
Eur J Endocrinol; 1999 Jul; 141(1):90-2. PubMed ID: 10407229
[TBL] [Abstract][Full Text] [Related]
16. The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity.
Hamer OW; Forstner D; Ottinger I; Ristow M; Bollheimer LC; Schölmerich J; Palitzsch KD
Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):230-4. PubMed ID: 12148087
[TBL] [Abstract][Full Text] [Related]
17. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
[TBL] [Abstract][Full Text] [Related]
18. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes.
Clement K; Hercberg S; Passinge B; Galan P; Varroud-Vial M; Shuldiner AR; Beamer BA; Charpentier G; Guy-Grand B; Froguel P; Vaisse C
Int J Obes Relat Metab Disord; 2000 Mar; 24(3):391-3. PubMed ID: 10757637
[TBL] [Abstract][Full Text] [Related]
19. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.
Rosmond R; Chagnon M; Bouchard C
Diabetes Metab Res Rev; 2003; 19(2):159-63. PubMed ID: 12673785
[TBL] [Abstract][Full Text] [Related]
20. Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort.
Schäffler A; Barth N; Schmitz G; Zietz B; Palitzsch KD; Schölmerich J
Endocrine; 2001 Apr; 14(3):369-73. PubMed ID: 11444435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
